PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25056761-0	2015	Relationship between SLCO1B3 and ABCA3 polymorphisms and imatinib response in chronic myeloid leukemia patients.	Imatinib Mesylate	57-65	ATP binding cassette subfamily A member 3	Homo sapiens	33-38	
23432194-3	2013	ABCA3 protected leukaemic cells from the cytotoxic effects of the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib.	Imatinib Mesylate	93-101	ATP binding cassette subfamily A member 3	Homo sapiens	0-5	
19880777-6	2009	Functionally, ABCA3 levels are critical for the susceptibility of chronic myeloid leukemia blast cell lines to specific BCR-ABL inhibition by imatinib.	Imatinib Mesylate	142-150	ATP binding cassette subfamily A member 3	Homo sapiens	14-19	
19880777-8	2009	The lysosomal storage capacity increases with ABCA3 expression, thus regulating imatinib sequestration.	Imatinib Mesylate	80-88	ATP binding cassette subfamily A member 3	Homo sapiens	46-51